Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lider

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Journal of Autoimmunity|February 1, 1989
Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccinationE Beraud, O Lider, E Baharav, et al.
Journal of Autoimmunity|February 1, 1989
Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector T cells. (2). Induction of a protective anti-idiotypic responseO Lider, E Beraud, T Reshef, et al.
European Journal of Immunology|November 1, 1987
Activation of specific T cell lines by the antigens avidin and myelin basic protein in the absence of antigen-presenting cellsD M Altmann, O Lider, D C Douek, et al.
The Israel Medical Association Journal : IMAJ|July 26, 2000
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injuryR Bruck, R Hershkoviz, O Lider, et al.
Journal of Leukocyte Biology|April 20, 2001
Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytesG G Vaday, H Schor, M A Rahat, et al.
Science (New York, N.Y.)|January 8, 1988
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitisO Lider, T Reshef, E Beraud, et al.
International Journal of Peptide and Protein Research|May 1, 1994
Novel psi-S-CH2 peptide-bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu-Asp-Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectinN Greenspoon, R Hershkoviz, R Alon, et al.
Cellular Immunology|October 1, 1992
Involvement of a protein kinase C and protein phosphatases in adhesion of CD4+ T cells to and detachment from extracellular matrix proteinsS Miron, R Hershkoviz, I Tirosh, et al.
The Yale Journal of Biology and Medicine|July 1, 1997
The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injuryR Bruck, R Hershkoviz, O Lider, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alphaB Shenkman, A Brill, G Brill, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Journal of Autoimmunity|February 1, 1989
Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccinationE Beraud, O Lider, E Baharav, et al.
Journal of Autoimmunity|February 1, 1989
Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector T cells. (2). Induction of a protective anti-idiotypic responseO Lider, E Beraud, T Reshef, et al.
European Journal of Immunology|November 1, 1987
Activation of specific T cell lines by the antigens avidin and myelin basic protein in the absence of antigen-presenting cellsD M Altmann, O Lider, D C Douek, et al.
The Israel Medical Association Journal : IMAJ|July 26, 2000
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injuryR Bruck, R Hershkoviz, O Lider, et al.
Journal of Leukocyte Biology|April 20, 2001
Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytesG G Vaday, H Schor, M A Rahat, et al.
Science (New York, N.Y.)|January 8, 1988
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitisO Lider, T Reshef, E Beraud, et al.
International Journal of Peptide and Protein Research|May 1, 1994
Novel psi-S-CH2 peptide-bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu-Asp-Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectinN Greenspoon, R Hershkoviz, R Alon, et al.
Cellular Immunology|October 1, 1992
Involvement of a protein kinase C and protein phosphatases in adhesion of CD4+ T cells to and detachment from extracellular matrix proteinsS Miron, R Hershkoviz, I Tirosh, et al.
The Yale Journal of Biology and Medicine|July 1, 1997
The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injuryR Bruck, R Hershkoviz, O Lider, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alphaB Shenkman, A Brill, G Brill, et al.
Pageof 10